The USA’s global share of biomedical research spending fell from 51% in 2007 to 45% in 2012, while Japan and China saw dramatic increases in research spending.
R&D spending in the USA dropped from $131 billion to $119 billion, when adjusted for inflation, from 2007-2012, while Japan increased spending by $9 billion and China rose by $6.4 billion. Overall, Asia's share of spending grew from 18% to 24%. Europe held steady at 29%. Prior analyses have suggested the USA’s share of global expenditures were once as high as 80%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze